BIO Protocol 扩展到 Solana，瞄准 DeSci 市场，融资 3300 万美元

BIO Protocol 是币安实验室支持的去中心化科学 (DeSci) 项目，正在扩展到 Solana。利用 Solana 的可扩展性和低廉费用，此举可能会彻底改变 DeSci 市场。

BIO Protocol, a decentralized science (DeSci) project backed by Binance Labs, is set to expand its operations to Solana. This move, capitalizing on Solana's scalability and low transaction fees, could revolutionize the DeSci market. Backed by $33 million in funding, BIO Protocol aims to transform the funding and commercialization of early-stage scientific research.

BIO Protocol 是一个由 Binance Labs 支持的去中心化科学 (DeSci) 项目，计划将其业务扩展到 Solana。这一举措利用了 Solana 的可扩展性和低交易费用，可能会彻底改变 DeSci 市场。 BIO Protocol 获得 3300 万美元的资金支持，旨在改变早期科学研究的资助和商业化。

Currently operating on Ethereum with seven "BioDAOs," BIO Protocol is expanding its presence by integrating with Solana and other blockchains. This launch marks a significant step in highlighting the growing potential of Solana's ecosystem in driving innovation within the DeSci domain.

BIO Protocol 目前在以太坊上运行，拥有七个“BioDAO”，正在通过与 Solana 和其他区块链集成来扩大其影响力。此次发布标志着 Solana 生态系统在推动 DeSci 领域创新方面不断增长的潜力迈出了重要一步。

The protocol is engaged in researching cryopreservation, women's health, and psychedelics for mental health. It plans to expand its research initiatives to cover chronic diseases and COVID. Notably, BIO Protocol's founder and CEO, Paul Kohlhaas, announced the Solana launch on X, hinting at potential airdrops to major pharmaceutical companies.

该协议致力于研究低温保存、妇女健康和心理健康迷幻药。它计划扩大其研究计划以涵盖慢性病和新冠病毒。值得注意的是，BIO Protocol 的创始人兼首席执行官 Paul Kohlhaas 宣布在 X 上推出 Solana，暗示可能会向主要制药公司进行空投。

Moreover, BIO Protocol will be participating in the upcoming JP Morgan Healthcare Conference, showcasing the increasing convergence between digital assets and healthcare.

此外，BIO Protocol 将参加即将举行的摩根大通医疗保健会议，展示数字资产与医疗保健之间的日益融合。

The DeSci sector is currently valued at $1.18 billion, with $185.6 million of tokens traded in the past 24 hours. Among the top DeSci tokens are OriginTrail (TRAC), VitaDAO (VITA), ResearchCoin (RSC), Hippocrat (HPO), and AxonDAO Governance Token (AXGT).

DeSci 行业目前估值为 11.8 亿美元，过去 24 小时内交易了 1.856 亿美元的代币。顶级 DeSci 代币包括 OriginTrail (TRAC)、VitaDAO (VITA)、ResearchCoin (RSC)、Hippocrat (HPO) 和 AxonDAO 治理代币 (AXGT)。

VITA and RSC have seen an impressive surge in the past seven days, with gains of 61% and 33%, respectively. In contrast, TRAC and AXGT faced declines of 11.4% and 5.7%, respectively. Other DeSci projects also experienced a downturn last week, with Urolithin A ($URO) falling 20.6% and Rifampicin ($RIF) crashing 13.6%. However, $RIF shot up 50% in the past 24 hours.

VITA 和 RSC 在过去 7 天里出现了令人印象深刻的飙升，涨幅分别为 61% 和 33%。相比之下，TRAC 和 AXGT 分别下跌 11.4% 和 5.7%。其他 DeSci 项目上周也经历了低迷，尿石素 A ($URO) 下跌 20.6%，利福平 ($RIF) 暴跌 13.6%。然而，$RIF 在过去 24 小时内飙升了 50%。

This article's content is solely intended for informational and educational purposes and does not constitute financial advice or any other form of advice. Coin Edition and its team are not liable for any losses incurred as a consequence of utilizing the content, products, or services covered in the article. Before taking any actions pertaining to the company, readers are advised to conduct their own thorough research and consult a qualified financial adviser.

本文内容仅供参考和教育目的，并不构成财务建议或任何其他形式的建议。 Coin Edition 及其团队对因使用本文所述内容、产品或服务而造成的任何损失不承担任何责任。在采取与公司有关的任何行动之前，建议读者进行彻底的研究并咨询合格的财务顾问。